104 related articles for article (PubMed ID: 11372669)
1. Coagulation factor VII in middle-aged women with and without coronary heart disease.
Eriksson-Berg M; Silveira A; Orth-Gomér K; Hamsten A; Schenck-Gustafsson K
Thromb Haemost; 2001 May; 85(5):787-92. PubMed ID: 11372669
[TBL] [Abstract][Full Text] [Related]
2. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
Thromb Haemost; 1994 Jun; 71(6):707-12. PubMed ID: 7974336
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism.
Silveira A; Green F; Karpe F; Blombäck M; Humphries S; Hamsten A
Thromb Haemost; 1994 Nov; 72(5):734-9. PubMed ID: 7900081
[TBL] [Abstract][Full Text] [Related]
5. [Plasma activated coagulation factor VII and Msp I polymorphism in elderly patients with coronary heart disease].
Lu QH; Du YM; Dong ZQ; Lu FH; Wen PE; Wang KZ; Tian Q; Sun H; Shang Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):691-3. PubMed ID: 16331575
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Morrissey JH
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen and factor VIIag in healthy adolescents: the Floren-teen (Florence teenager) Study.
Prisco D; Fedi S; Brunelli T; Cellai AP; Hagi MI; Gianni R; Santoro E; Cappelletti C; Pepe G; Gensini GF; Abbate R
Thromb Haemost; 1996 May; 75(5):778-81. PubMed ID: 8725723
[TBL] [Abstract][Full Text] [Related]
8. Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease.
Eriksson-Berg M; Deguchi H; Hawe E; Scanavini D; Orth-Gomér K; Schenck-Gustafsson K; Humphries SE; Silveira A; Hamsten A
Thromb Haemost; 2005 Feb; 93(2):351-8. PubMed ID: 15711754
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
12. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
Albert CM; Chae CU; Rexrode KM; Manson JE; Kawachi I
Circulation; 2005 Feb; 111(4):480-7. PubMed ID: 15687137
[TBL] [Abstract][Full Text] [Related]
13. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
[TBL] [Abstract][Full Text] [Related]
14. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
15. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
[TBL] [Abstract][Full Text] [Related]
16. Conventional risk factors and acute coronary syndrome during a period of socioeconomic transition: population-based case-control study in Tirana, Albania.
Burazeri G; Goda A; Sulo G; Stefa J; Roshi E; Kark JD
Croat Med J; 2007 Apr; 48(2):225-33. PubMed ID: 17436387
[TBL] [Abstract][Full Text] [Related]
17. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
[TBL] [Abstract][Full Text] [Related]
18. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Boekholdt SM; Peters RJ; Hack CE; Day NE; Luben R; Bingham SA; Wareham NJ; Reitsma PH; Khaw KT
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1503-8. PubMed ID: 15178568
[TBL] [Abstract][Full Text] [Related]
19. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
